Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers

References

• Hahne JC, Valeri N. Non-coding RNAs and resistance to anticancer drugs in gastrointestinal tumors. Front Oncol. 2018;8:226.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinicians. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. Ca A Cancer J Clinicians. 2019;69(5):363–385.
   PubMed Web of Science ®Google Scholar
• Griffin-Sobel JP. Gastrointestinal cancers: screening and early detection. Semin Oncol Nurs. 2017;33(2):165–171. Seminars in oncology nursing, Elsevier. doi: 10.1016/j.soncn.2017.02.004
   PubMed Web of Science ®Google Scholar
• Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147(4):742–758.
   PubMed Web of Science ®Google Scholar
• Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J. 2011;30(18):3667–3683.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890.
   PubMed Web of Science ®Google Scholar
• Li J, Chai R, Chen Y, et al. Curcumin targeting non-coding RNAs in colorectal cancer: therapeutic and biomarker implications. Biomolecules. 2022;12(10):1339.
   PubMed Web of Science ®Google Scholar
• Pfeffer CM, Singh ATK. Apoptosis: a target for anticancer therapy. Int J Mol Sci. 2018Feb;19(2):448. doi: 10.3390/ijms19020448
   PubMed Web of Science ®Google Scholar
• Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol. 2011;27:347–376.
   PubMed Web of Science ®Google Scholar
• Frisch SM, Schaller M, Cieply B. Mechanisms that link the oncogenic epithelial–mesenchymal transition to suppression of anoikis. J Cell Sci. 2013;126(1):21–29.
   PubMed Web of Science ®Google Scholar
• Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nature Med. 2015;21(9):998–1009.
   PubMed Web of Science ®Google Scholar
• Emamgolizadeh Gurt Tapeh B, Mosayyebi B, Samei M, et al. microRnas involved in T‐cell development, selection, activation, and hemostasis. J Cell Physiol. 2020;235(11):8461–8471.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Adelian S, Shakerian S, et al. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy. Cytokine Growth Factor Rev. 2022;64:33–45.
   PubMed Web of Science ®Google Scholar
• Song J, Shi W. The concomitant apoptosis and EMT underlie the fundamental functions of TGF-β. Acta Biochim Biophys Sin (Shanghai). 2018;50(1):91–97.
   PubMed Web of Science ®Google Scholar
• Clark CR, Robinson JY, Sanchez NS, et al. Common pathways regulate type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells. Cell Signal. 2016;28(6):688–698.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Kharazmi K, Ghanaatian M, et al. Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment. Cytokine Growth Factor Rev. 2022;67:11–24.
   PubMed Web of Science ®Google Scholar
• Howard S, Deroo T, Fujita Y, et al. A positive role of cadherin in Wnt/β-catenin signalling during epithelial-mesenchymal transition. PLoS One. 2011;6(8):e23899.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Kong D, et al. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 2010;11(6):745–751.
   PubMed Web of Science ®Google Scholar
• Adelian S, Ahadi AM, Ayat H, et al. Enhanced recombinant C-terminal domain of gli2 gene expression can improve wound healing through promoting cdc25b and N-Myc genes expression. Gene Rep. 2020;20:100754.
   Web of Science ®Google Scholar
• Li Q, Wang J, He Y, et al. MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain. Cell Death Dis. 2014;5(4):e1197–e1197.
   PubMedGoogle Scholar
• Drak Alsibai K, Meseure D. Tumor microenvironment and noncoding RNAs as co‐drivers of epithelial–mesenchymal transition and cancer metastasis. Dev Dyn. 2018;247(3):405–431.
   PubMed Web of Science ®Google Scholar
• Su Y, Wu H, Pavlosky A, et al. Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death Dis. 2016;7(8):e2333–e2333.
   PubMedGoogle Scholar
• Nicolas E. Role of ncRnas in development, diagnosis and treatment of human cancer. Recent Patents Anti-Cancer Drug Disc. 2017;12(2):128–135.
   PubMed Web of Science ®Google Scholar
• Salviano-Silva A, Lobo-Alves SC, Almeida RCD, et al. Besides pathology: long non-coding RNA in cell and tissue homeostasis. Noncoding RNA. 2018;4(1):3.
   PubMedGoogle Scholar
• Dasgupta P, Kulkarni P, Majid S, et al. MicroRNA-203 inhibits long noncoding RNA HOTAIR and regulates tumorigenesis through epithelial-to-mesenchymal transition pathway in renal cell carcinoma. Mol Cancer Ther. 2018;17(5):1061–1069.
   PubMed Web of Science ®Google Scholar
• Li J, Huang Y, Deng X, et al. Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial–mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells. Onco Targets Ther. 2018;11:427.
   PubMed Web of Science ®Google Scholar
• Hu D, Shen D, Zhang M, et al. MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma. Am J Cancer Res. 2017;7(10):2070.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang W, Hu Z, et al. Hypoxia and lncRnas in gastrointestinal cancers. Pathol Res Pract. 2019;215(12):152687.
   PubMed Web of Science ®Google Scholar
• Zhou W, Ye X-L, Xu J, et al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci Signaling. 2017;10(483) doi: 10.1126/scisignal.aak9557
   Web of Science ®Google Scholar
• Abdi E, Latifi-Navid S, Abdi F, et al. Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Rev Mol Diagn. 2020;20(11):1121–1138.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Parkhideh S, Samizade S, et al. Crosstalk between lncRnas in the apoptotic pathway and therapeutic targets in cancer. Cytokine Growth Factor Rev. 2022;65:61–74.
   PubMed Web of Science ®Google Scholar
• Felekkis K, Touvana E, Stefanou C, et al. microRnas: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. 2010;14(4):236.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions. In: Feng Y, Zhang L, editors. Long non-coding RNAs. Springer Science, Business Media New York; 2016. pp. 271–286.
   Google Scholar
• Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in Human Cancer. In: Schmitz U, Wolkenhauer O, Vera J, editors. MicroRNA Cancer Regulation. Advances in Experimental Medicine and Biology. Vol. 774. Springer, Dordrecht; 2013. doi: 10.1007/978-94-007-5590-1_1
   Google Scholar
• Guzel E, Okyay TM, Yalcinkaya B, et al. Tumor suppressor and oncogenic role of long non-coding RNAs in cancer. North Clin Istanb. 2020;7(1):81.
   PubMed Web of Science ®Google Scholar
• Saberinia A, Alinezhad A, Jafari F, et al. Oncogenic miRnas and target therapies in colorectal cancer. Clinica Chimica Acta. 2020;508:77–91.
   PubMed Web of Science ®Google Scholar
• Wu S-R, Wu Q, Shi Y-Q. Recent advances of miRnas in the development and clinical application of gastric cancer. Chinese Med J. 2020;133(15):1856.
   PubMed Web of Science ®Google Scholar
• Shin VY, Chu K-M. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol. 2014;20(30):10432.
   PubMed Web of Science ®Google Scholar
• Stark VA, Facey CO, Viswanathan V, et al. The role of miRnas, miRNA clusters, and isomiRs in development of cancer stem cell populations in colorectal cancer. Int J Mol Sci. 2021;22(3):1424.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838.
   PubMed Web of Science ®Google Scholar
• Lima RT, Busacca S, Almeida GM, et al. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer. 2011;47(2):163–174.
   PubMed Web of Science ®Google Scholar
• Guo S-L, Peng Z, Yang X, et al. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci. 2011;7(5):567.
   PubMed Web of Science ®Google Scholar
• Zheng B, Liang L, Wang C, et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res. 2011;17(24):7574–7583.
   PubMed Web of Science ®Google Scholar
• Liang H, Wang F, Chu D, et al. miR-93 functions as an oncomiR for the downregulation of PDCD4 in gastric carcinoma. Sci Rep. 2016;6(1):1–11.
   PubMedGoogle Scholar
• Wei H, Yang Z, Lin B. Overexpression of long non coding RNA CA3-AS1 suppresses proliferation, invasion and promotes apoptosis via miRNA-93/PTEN axis in colorectal cancer. Gene. 2019;687:9–15.
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Ohno S, Wu W, et al. miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer. Cancer Sci. 2011;102(12):2264–2271.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Mullany LE, Sakoda LC, et al. Dysregulated genes and miRnas in the apoptosis pathway in colorectal cancer patients. Apoptosis. 2018;23(3):237–250.
   PubMed Web of Science ®Google Scholar
• Yu J, Ni Q, Zhang S, et al. MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene. Cell Mol Biol. 2020;66(1):95–100.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu J, Yin J, et al. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. Die Pharmazie- Int J Pharm Sci. 2012;67(7):645–651.
   Google Scholar
• Li D, Zhao Y, Liu C, et al. Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res. 2011;17(7):1722–1730.
   PubMed Web of Science ®Google Scholar
• Miraghel SA, Ebrahimi N, Khani L, et al. Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer. Pharmacol Res. 2022;176:106041.
   PubMed Web of Science ®Google Scholar
• Nie H, Mu J, Wang J, et al. MiR‑195‑5p regulates multi‑drug resistance of gastric cancer cells via targeting ZNF139. Oncol Rep. 2018;40(3):1370–1378.
   PubMed Web of Science ®Google Scholar
• Li B, Wang S, Wang S. MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A. Mol Genet Genomic. 2018;293(5):1245–1253.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun. 2010;400(2):236–240.
   PubMed Web of Science ®Google Scholar
• Cole KA, Attiyeh EF, Mosse YP, et al. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res. 2008;6(5):735–742.
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Nat Acad Sci. 2008;105(36):13421–13426. doi: 10.1073/pnas.0801613105
   PubMed Web of Science ®Google Scholar
• Cao W, Fan R, Wang L, et al. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumor Biol. 2013;34(2):963–971.
   PubMedGoogle Scholar
• Zhang J-X, Xu Y, Gao Y, et al. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway. Mol Cancer. 2017;16(1):18.
   PubMed Web of Science ®Google Scholar
• Wang L-L, Wang L, Wang X-Y, et al. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1. Tumour Biol. 2016;37(11):15241–15252.
   PubMedGoogle Scholar
• Meng Q, Chen Y, Lian B, et al. MiR‑218 promotes apoptosis of SW1417 human colon cancer cells by targeting c‑FLIP. Oncol Rep. 2018;40(2):916–922.
   PubMed Web of Science ®Google Scholar
• Li G, Yang F, Gu S, et al. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C. Mol Med Rep. 2016;13(1):572–578.
   PubMed Web of Science ®Google Scholar
• Si Y, Yang Z, Ge Q, et al. Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer. Cell Mol Biol Lett. 2019;24(1):50.
   PubMedGoogle Scholar
• Chen J, Zhou C, Li J, et al. MiR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med. 2018;41(4):1855–1866.
   PubMed Web of Science ®Google Scholar
• Xiong B, Cheng Y, Ma L, et al. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int J Oncol. 2013;42(1):219–228.
   PubMed Web of Science ®Google Scholar
• Jin B, Liu Y, Wang H. Antagonism of miRNA-21 sensitizes human gastric cancer cells to paclitaxel. Cell Biochem Biophys. 2015;72(1):275–282.
   PubMed Web of Science ®Google Scholar
• Lee SD, Yu D, Lee DY, et al. Upregulated microRNA‐193a‐3p is responsible for cisplatin resistance in CD 44 (+) gastric cancer cells. Cancer Sci. 2019;110(2):662–673.
   PubMed Web of Science ®Google Scholar
• Wang J, Yang J, Zhang H, et al. Effects of miR-135a-5p and miR-141 on proliferation, invasion and apoptosis of colorectal cancer SW620 cells. Oncol Lett. 2020;20(1):914–920.
   PubMed Web of Science ®Google Scholar
• Shao L, Chen Z, Soutto M, et al. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer. FASEB J. 2019;33(1):264–274.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang X, Zhang H, et al. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Oncogene. 2021;40:4695–4708. doi: 10.1038/s41388-021-01898-z
   PubMed Web of Science ®Google Scholar
• Shang Y, Zhang Z, Liu Z, et al. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene. 2014;33(25):3267–3276.
   PubMed Web of Science ®Google Scholar
• Wang F, Li T, Zhang B, et al. MicroRNA-19a/B regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun. 2013;434(3):688–694.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen X, Chen X, et al. Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer. Cell Death Dis. 2020;11(3):1–14.
   PubMed Web of Science ®Google Scholar
• Liu X, Cui L, Hua D. Long noncoding RNA XIST regulates miR-137-EZH2 axis to promote tumor metastasis in colorectal cancer. Oncol Res. 2018;27(1):99–106.
   PubMed Web of Science ®Google Scholar
• Fang Y, Shen H, Li H, et al. miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells. Acta Biochim Biophys Sin. 2013;45(11):963–972.
   Google Scholar
• Hao H, Xia G, Wang C, et al. miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7. Med Mol Morphol. 2017;50(2):76–85.
   PubMed Web of Science ®Google Scholar
• Lu L, Cai M, Peng M, et al. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer. Cancer Manage Res. 2019;11:1805.
   PubMed Web of Science ®Google Scholar
• Zhou N, Qu Y, Xu C, et al. Upregulation of microRNA‑375 increases the cisplatin‑sensitivity of human gastric cancer cells by regulating ERBB2. Exp Ther Med. 2016;11(2):625–630.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen X, Xu M, et al. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells. Aging. 2019;11(18):7357–7385.
   PubMedGoogle Scholar
• Xian Z, Hu B, Wang T, et al. lncRNA UCA1 contributes to 5-fluorouracil resistance of colorectal cancer cells through miR-23b-3p/znf281 axis. Onco Targets Ther. 2020;13:7571.
   PubMed Web of Science ®Google Scholar
• Eto K, Iwatsuki M, Watanabe M, et al. The sensitivity of gastric cancer to trastuzumab is regulated by the mi R‐223/FBXW 7 pathway. Int J Cancer. 2015;136(7):1537–1545.
   PubMed Web of Science ®Google Scholar
• Ju H, Tan J, Cao B, et al. Effects of miR-223 on colorectal cancer cell proliferation and apoptosis through regulating FoxO3a/BIM. Eur Rev Med Pharmacol Sci. 2018;22(12):3771–3778.
   PubMed Web of Science ®Google Scholar
• Ge X, Liu X, Lin F, et al. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer. Oncotarget. 2016;7(17):24466.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cheng X, Wan Y, et al. MicroRNA-421 inhibits apoptosis by downregulating caspase-3 in human colorectal cancer. Cancer Manage Res. 2020;12:7579.
   PubMed Web of Science ®Google Scholar
• Zhang L, He L, Zhang H, et al. Knockdown of MiR-20a enhances sensitivity of colorectal cancer cells to cisplatin by increasing ASK1 expression. Cell Physiol Biochem. 2018;47(4):1432–1441.
   PubMedGoogle Scholar
• Zhou L, Li X, Zhou F, et al. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance. Cancer Sci. 2018;109(4):1044–1054.
   PubMed Web of Science ®Google Scholar
• Cao W, Wei W, Zhan Z, et al. MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1. Oncol Rep. 2016;35(5):2583–2591.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zuo J, Liu Y, et al. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells. Chinese J Cancer. 2010;29(12):1006–1011.
   PubMedGoogle Scholar
• Gao Z, Zhou H, Wang Y, et al. Regulatory effects of lncRNA ATB targeting miR‐200c on proliferation and apoptosis of colorectal cancer cells. J Cell Biochem. 2020;121(1):332–343.
   PubMed Web of Science ®Google Scholar
• Han X, Zhang J-J, Han Z-Q, et al. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB. Cancer Genet Ther. 2018;25(11):300–308.
   PubMed Web of Science ®Google Scholar
• Karaayvaz M, Zhai H, Ju J. miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer. Cell Death Dis. 2013;4(6):e659–e659.
   PubMedGoogle Scholar
• Lu C, Shan Z, Li C, et al. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp. Biomed Pharmacother. 2017;86:450–456.
   PubMed Web of Science ®Google Scholar
• Wang T, Ge G, Ding Y, et al. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targetingIgf1randbcl2. Chinese Med J. 2014;127(12):2357–2362.
   PubMed Web of Science ®Google Scholar
• Chang S-W, Yue J, Wang B-C, et al. miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol. 2015;8(10):12853.
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, et al. miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer. 2008;123(2):372–379.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao Q, Zhang C, et al. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis. Sci Rep. 2017;7(1):1–12.
   PubMed Web of Science ®Google Scholar
• Wang Z, Ji F. Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21. Oncol Lett. 2018;15(4):4585–4591.
   PubMed Web of Science ®Google Scholar
• Yu W, Wang J, Li C, et al. miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2. J Cancer. 2022 Jan 1;13(3):918–931. doi: 10.7150/jca.65614
   PubMed Web of Science ®Google Scholar
• Yang F, Chen X, Li X, et al. Long Intergenic non-protein coding RNA 1089 suppresses cell proliferation and metastasis in gastric cancer by regulating miRNA-27a-3p/Epithelial–Mesenchymal transition (EMT) axis. Cancer Manage Res. 2020;12:5587.
   PubMed Web of Science ®Google Scholar
• Yao H, Sun Q, Zhu J. miR‑1271 enhances the sensitivity of colorectal cancer cells to cisplatin. Exp Ther Med. 2019 Jun 1;17(6):4363–4370.
   PubMed Web of Science ®Google Scholar
• Chai J, Dong W, Xie C, et al. Micro RNA‐494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD. IUBMB Life. 2015;67(3):191–201.
   PubMed Web of Science ®Google Scholar
• Xu S, Li D, Li T, et al. miR-494 sensitizes gastric cancer cells to TRAIL treatment through downregulation of survivin. Cell Physiol Biochem. 2018;51(5):2212–2223.
   PubMedGoogle Scholar
• Hu S, Liu L, Chang EB, et al. Butyrate inhibits pro-proliferative miR-92a by diminishing c-myc-induced miR-17-92a cluster transcription in human colon cancer cells. Mol Cancer. 2015;14(1):1–15.
   PubMedGoogle Scholar
• Chen D-L, Chen L-Z, Lu Y-X, et al. Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer. Cell Death Dis. 2017;8(8):e3011–e3011.
   PubMedGoogle Scholar
• Peng H, Luo J, Hao H, et al. MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B. Oncol Rep. 2014;31(5):2055–2062.
   PubMed Web of Science ®Google Scholar
• Peng C-W, Yue L-X, Zhou Y-Q, et al. miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2. Cancer Cell Int. 2019;19(1):1–13.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xu X, Zhao S, et al. The expression and significance of the plasma let-7 family in anti-N-methyl-D-aspartate receptor encephalitis. J Mol Neurosci. 2015;56(3):531–539.
   PubMed Web of Science ®Google Scholar
• Qi B, Dong Y, Qiao X. Effects of miR-18a on proliferation and apoptosis of gastric cancer cells by regulating RUNX1. Eur Rev Med Pharmacol Sci. 2020;24(19):9957–9964.
   PubMed Web of Science ®Google Scholar
• Tong Z, Liu N, Lin L, et al. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. Biomed Pharmacother. 2015;75:129–136.
   PubMed Web of Science ®Google Scholar
• Ren X, He G, Li X, et al. MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. J Cancer Res Clin Oncol. 2016;142(3):581–592.
   PubMed Web of Science ®Google Scholar
• Deng M, Qin Y, Chen X, et al. MiR-206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the MUC1 gene. Onco Targets Ther. 2019;12:849.
   PubMed Web of Science ®Google Scholar
• Tagscherer KE, Fassl A, Sinkovic T, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16(1):1–12.
   PubMedGoogle Scholar
• Zhao D, Wu Q. Effect of inhibition to yes-related proteins-mediated Wnt/β-catenin signaling pathway through miR-195-5p on apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci. 2019;23(15):6486–6496.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li Y, Huang Q, et al. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Diff. 2011;18(11):1702–1710.
   PubMed Web of Science ®Google Scholar
• Li B, Wang W, Li Z, et al. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression. Cancer Lett. 2017;410:212–227.
   PubMed Web of Science ®Google Scholar
• Sun S, Hang T, Zhang B, et al. miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway. Am J Transl Res. 2019;11(9):5338.
   PubMed Web of Science ®Google Scholar
• Wang H, Xu T, Wu L, et al. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells. Eur Rev Med Pharmacol Sci. 2020;24(5):2452–2461.
   PubMed Web of Science ®Google Scholar
• Perilli L, Tessarollo S, Albertoni L, et al. Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer. BMC Cancer. 2019;19(1):1–13.
   PubMed Web of Science ®Google Scholar
• Huang XX, Zhang Q, Hu H, et al. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR‐182‐5p. J Cell Biochem. 2020 Jan 2. doi:10.1002/jcb.29641
   Web of Science ®Google Scholar
• Chen J, Wang M-B. The roles of miRNA-143 in colon cancer and therapeutic implications. Translational Gastrointestinal Cancer. 2012;1(2):169–174.
   Google Scholar
• Guoping M, Ran L, Yanru Q. miR-143 inhibits cell proliferation of gastric cancer cells through targeting GATA6. Oncol Res. 2018;26(7):1023.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu J, Liu H, et al. Novel epigenetic CREB-miR-630 signaling axis regulates radiosensitivity in colorectal cancer. PLoS One. 2015;10(8):e0133870.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu M, Lu P, et al. microRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1. Onco Targets Ther. 2018;11:9013.
   PubMed Web of Science ®Google Scholar
• Jin Y, Cheng H, Cao J, et al. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3. J Cell Biochem. 2019;120(11):18629–18639.
   PubMed Web of Science ®Google Scholar
• Zhang J-X, Song W, Chen Z-H, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013;14(13):1295–1306.
   PubMed Web of Science ®Google Scholar
• Du M, Liu S, Gu D, et al. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis. 2014;35(12):2723–2730.
   PubMed Web of Science ®Google Scholar
• Huang L, Wang X, Wen C, et al. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep. 2015;5(1):1–12.
   Google Scholar
• Lu W-D, Zuo Y, Xu Z, et al. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. World J Gastroenterol. 2015;21(15):4564.
   PubMed Web of Science ®Google Scholar
• Sabry D, El-Deek SE, Maher M, et al. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Mol Cell Biochem. 2019;454(1):177–189.
   PubMed Web of Science ®Google Scholar
• Sun Y, Tian H, Wang L. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway. Oncol Rep. 2015;33(4):1828–1836.
   PubMed Web of Science ®Google Scholar
• Xu G, Meng L, Yuan D, et al. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer. Oncol Rep. 2018;40(1):39–48.
   PubMed Web of Science ®Google Scholar
• Tang X, Yang M, Wang Z, et al. MicroRNA-23a promotes colorectal cancer cell migration and proliferation by targeting at MARK1. Acta Biochim Biophys Sin (Shanghai). 2019;51(7):661–668.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang Y, Liang H, et al. miR-23a/B promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer. Cell Death Dis. 2017;8(10):e3059–e3059.
   PubMed Web of Science ®Google Scholar
• Zheng H, Li W, Wang Y, et al. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis. 2014;35(1):173–183.
   PubMed Web of Science ®Google Scholar
• Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal. 2003;15(11):983–992.
   PubMed Web of Science ®Google Scholar
• Zheng H, Cai Y, Wang Y, et al. Fas signaling promotes motility and metastasis through epithelial–mesenchymal transition in gastrointestinal cancer. Oncogene. 2013;32(9):1183–1192.
   PubMed Web of Science ®Google Scholar
• Nishida N, Nagahara M, Sato T, et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin Cancer Res. 2012;18(11):3054–3070.
   PubMed Web of Science ®Google Scholar
• Zhang G, Zhou H, Xiao H, et al. MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN. Dig Dis Sci. 2014;59(1):98–107.
   PubMed Web of Science ®Google Scholar
• Tang W, Zhu Y, Gao J, et al. MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4. Br J Cancer. 2014;110(2):450–458.
   PubMed Web of Science ®Google Scholar
• Liu L-Q, Hu L, Hu X-B, et al. MiR-92a antagonized the facilitation effect of extracellular matrix protein 1 in GC metastasis through targeting its 3′UTR region. Food Chem Toxicol. 2019;133:110779.
   PubMed Web of Science ®Google Scholar
• Bornachea O, Santos M, Martínez-Cruz AB, et al. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Sci Rep. 2012;2(1):434.
   PubMedGoogle Scholar
• Zhang W, Zhang T, Jin R, et al. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res. 2014;33(1):1–13.
   PubMedGoogle Scholar
• Orosz E, Kiss I, Gyöngyi Z, et al. Expression of circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: comparison of colonic and rectal cancer. In Vivo. 2018;32(6):1333–1337.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zheng X, Chen L, et al. Smad2/3/4 pathway contributes to TGF-β-induced miRNA-181b expression to promote gastric cancer metastasis by targeting Timp3. Cell Physiol Biochem. 2016;39(2):453–466.
   PubMedGoogle Scholar
• Gu X, Jin R, Mao X, et al. Prognostic value of miRNA-181a/b in colorectal cancer: a meta-analysis. Biomark Med. 2018;12(3):299–308.
   PubMed Web of Science ®Google Scholar
• Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62(9):1315–1326.
   PubMed Web of Science ®Google Scholar
• Adamopoulos PG, Kontos CK, Rapti S-M, et al. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Int J Oncol. 2015;46(2):849–859.
   PubMed Web of Science ®Google Scholar
• Sun X, Lin F, Sun W, et al. Exosome-transmitted miRNA-335-5p promotes colorectal cancer invasion and metastasis by facilitating EMT via targeting RASA1. Mol Ther Nucleic Acids. 2021;24:164–174.
   PubMedGoogle Scholar
• Huang Y, Du X, Chen X, et al. MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling. J Cancer. 2021;12(18):5394.
   PubMed Web of Science ®Google Scholar
• Li L-Q, Pan D, Chen Q, et al. Sensitization of gastric cancer cells to 5-FU by microRNA-204 through targeting the TGFBR2-mediated epithelial to mesenchymal transition. Cell Physiol Biochem. 2018;47(4):1533–1545.
   PubMedGoogle Scholar
• Shuai F, Wang B, Dong S. MicroRNA-204 inhibits the growth and motility of colorectal cancer cells by downregulation of CXCL8. Oncol Res. 2018;26(8):1295.
   PubMed Web of Science ®Google Scholar
• Park Y, Kim S, Lee M, et al. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer. J Cancer Res Clin Oncol. 2017;143(10):1915–1927.
   PubMed Web of Science ®Google Scholar
• Wu D-M, Hong X-W, Wang L-L, et al. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer. Int J Biochem Cell Biol. 2018;102:59–70.
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee YS, Yun NH, et al. MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer. Br J Cancer. 2020;123(7):1123–1130.
   PubMed Web of Science ®Google Scholar
• Abdeahad H, Avan A, Pashirzad M, et al. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: a meta-analysis. J Cell Physiol. 2019;234(7):10926–10933.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.
   PubMed Web of Science ®Google Scholar
• Fang J, Chen W, Meng X-L. LncRNA CASC9 suppressed the apoptosis of gastric cancer cells through regulating BMI1. Pathol Oncol Res. 2020;26(1):475–482.
   PubMed Web of Science ®Google Scholar
• Fang Q, Chen X, Zhi X. Long non-coding RNA (LncRNA) Urothelial carcinoma associated 1 (UCA1) increases multi-drug resistance of gastric cancer via downregulating miR-27b. Med Sci Monit. 2016;22:3506–3513.
   PubMed Web of Science ®Google Scholar
• Han Y, Yang Y-N, Yuan H-H, et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology. 2014;46(5):396–401.
   PubMed Web of Science ®Google Scholar
• Li J, Gao J, Tian W, et al. Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297. Cancer Cell Int. 2017;17(1):44.
   PubMedGoogle Scholar
• Keyvani-Ghamsari S, Rabbani-Chadegani A, Sargolzaei J, et al. Effect of irinotecan on HMGB1, MMP9 expression, cell cycle, and cell growth in breast cancer (MCF-7) cells. Tumour Biol. 2017;39(4):1010428317698354.
   Google Scholar
• Cai X, Ding H, Liu Y, et al. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer. Acta Biochim Biophys Sin (Shanghai). 2017;49(2):119–127.
   PubMed Web of Science ®Google Scholar
• Cui G, Cai F, Ding Z, et al. HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. Hum Pathol. 2019;84:133–141.
   PubMed Web of Science ®Google Scholar
• Xu C, Yang M, Tian J, et al. MALAT-1: a long non-coding RNA and its important 3’ end functional motif in colorectal cancer metastasis. Int J Oncol. 2011;39(1):169–175.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang L, et al. lncRNA HOTAIR contributes to 5FU resistance through suppressing miR-218 and activating NF-κB/TS signaling in colorectal cancer. Mol Ther Nucleic Acids. 2017;8:356–369.
   PubMedGoogle Scholar
• Liu Y, Chen X, Chen X, et al. Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer. Cell Death Dis. 2020;11(3):175.
   PubMed Web of Science ®Google Scholar
• Cheng C, Qin Y, Zhi Q, et al. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. Int j biol macromol. 2018;107:2620–2629.
   PubMed Web of Science ®Google Scholar
• Dong X, He X, Guan A, et al. Long non-coding RNA hotair promotes gastric cancer progression via miR-217-GPC5 axis. Life Sci. 2019;217:271–282.
   PubMed Web of Science ®Google Scholar
• Zhuang M, Gao W, Xu J, et al. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448(3):315–322.
   PubMed Web of Science ®Google Scholar
• Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang J, Wang Y, et al. Long non-coding LEF1-AS1 sponge miR-5100 regulates apoptosis and autophagy in gastric cancer cells via the miR-5100/DEK/AMPK-mTOR axis. Int J Mol Sci. 2022 Apr 26;23(9):4787. doi: 10.3390/ijms23094787
   PubMed Web of Science ®Google Scholar
• Sun M, Jin F-Y, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14(1):319.
   PubMed Web of Science ®Google Scholar
• Yin D, He X, Zhang E, et al. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med Oncol. 2014;31(11):253.
   PubMed Web of Science ®Google Scholar
• Xu TP, Liu XX, Xia R, et al. SP1-induced upregulation of the long noncoding RNA TINCR regulates cell proliferation and apoptosis by affecting KLF2 mRNA stability in gastric cancer. Oncogene. 2015;34(45):5648–5661.
   PubMed Web of Science ®Google Scholar
• Zhang M, Huang S, Long D. MiR‑381 inhibits migration and invasion in human gastric carcinoma through downregulatedting SOX4. Oncol Lett. 2017;14(3):3760–3766.
   PubMed Web of Science ®Google Scholar
• O’Brien SJ, Bishop C, Hallion J, et al. Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review. Cancer Biol Ther. 2020;21(9):769–781.
   PubMed Web of Science ®Google Scholar
• Yan K, Tian J, Shi W, et al. LncRNA SNHG6 is associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through epigenetically silencing p27 and sponging miR-101-3p. Cell Physiol Biochem. 2017;42(3):999–1012.
   PubMed Web of Science ®Google Scholar
• Chen D-L, Ju H-Q, Lu Y-X, et al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin Cancer Res. 2016;35(1):142.
   PubMedGoogle Scholar
• Zhang Q, Chen B, Liu P, et al. XIST promotes gastric cancer (GC) progression through TGF-β1 via targeting miR-185. J Cell Biochem. 2018;119(3):2787–2796.
   PubMed Web of Science ®Google Scholar
• Song H, He P, Shao T, et al. Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. J Buon. 2017;22(3):696–703.
   PubMed Web of Science ®Google Scholar
• Chen D-L, Chen L-Z, Lu Y-X, et al. Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer. Cell Death Dis. 2017;8(8):e3011–e3011.
   PubMedGoogle Scholar
• Sun N, Zhang G, Liu Y. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway. Gene. 2018;665:141–148.
   PubMed Web of Science ®Google Scholar
• Liu A, Liu L, Lu H. LncRNA XIST facilitates proliferation and epithelial–mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2. J Cell Physiol. 2019;234(8):13747–13761.
   PubMed Web of Science ®Google Scholar
• Gong J, Wang Y, Shu C. LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(3):1168–1176.
   PubMed Web of Science ®Google Scholar
• Tao Y, Han T, Zhang T, et al. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway. Oncotarget. 2017;8(22):36410–36422.
   PubMedGoogle Scholar
• Zuo Z-K, Gong Y, Chen X-H, et al. TGFβ1-induced lncRNA UCA1 upregulation promotes gastric cancer invasion and migration. DNA Cell Biol. 2017;36(2):159–167.
   PubMed Web of Science ®Google Scholar
• Chen D, Liu L, Wang K, et al. The role of MALAT-1 in the invasion and metastasis of gastric cancer. Scand J Gastroenterol. 2017;52(6–7):790–796.
   PubMed Web of Science ®Google Scholar
• Xu Z-Y, Yu Q-M, Du Y-A, et al. Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci. 2013;9(6):587.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang G, Zhao J, et al. LncRNA H19 promoted the epithelial to mesenchymal transition and metastasis in gastric cancer via activating Wnt/β-catenin signaling. Dig Dis. 2021;40(4):436–447. doi: 10.1159/000518627
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen Z, Yan Y, et al. Long non‑coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer. Oncol Lett. 2017;13(5):3151–3158.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yin L, Chen C, et al. Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein. Digestive Liver Dis. 2020;52(3):331–338.
   Web of Science ®Google Scholar
• Ghafouri-Fard S, Dashti S, Taheri M, et al. TINCR: an lncRNA with dual functions in the carcinogenesis process. Noncoding RNA Res. 2020;5(3):109–115.
   PubMed Web of Science ®Google Scholar
• Li N, Shi K, Li W. TUSC7: a novel tumor suppressor long non‐coding RNA in human cancers. J Cell Physiol. 2018;233(9):6401–6407.
   PubMed Web of Science ®Google Scholar
• Zhang H, Song Y, Yang C, et al. Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer. Oncol Rep. 2019;41(6):3386–3392.
   PubMed Web of Science ®Google Scholar
• Xu Y-C, Liu X, Li M, et al. A novel mechanism of doxorubicin resistance and tumorigenesis mediated by microRNA-501-5p-suppressed BLID. Mol Ther Nucleic Acids. 2018;12:578–590.
   PubMedGoogle Scholar
• Wang W, Xie Y, Chen F, et al. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World J Gastroenterol. 2019;25(29):3972.
   PubMed Web of Science ®Google Scholar
• Sun T, Li K, Zhu K, et al. SNHG6 interacted with miR-325-3p to regulate cisplatin resistance of gastric cancer by targeting GITR. Onco Targets Ther. 2020;13:12181.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Chen B, Liu P, et al. XIST promotes gastric cancer (GC) progression through TGF‐β1 via targeting miR‐185. J Cell Biochem. 2018;119(3):2787–2796.
   PubMed Web of Science ®Google Scholar
• Chen W, Tu Q, Yu L, et al. LncRNA ADAMTS9-AS1, as prognostic marker, promotes cell proliferation and EMT in colorectal cancer. Hum Cell. 2020;33(4):1133–1141.
   PubMed Web of Science ®Google Scholar
• Zhang W, Yuan W, Song J, et al. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α. Biochimie. 2018;144:21–27.
   PubMed Web of Science ®Google Scholar
• Wang JZ, Xu CL, Wu H, et al. LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells. Braz J Med Biol Res. 2017 Feb 20;50:(3):e6079. doi: 10.1590/1414-431X20176079
   PubMed Web of Science ®Google Scholar
• Peng W, Wang Z, Fan H. LncRNA NEAT1 Impacts cell proliferation and apoptosis of colorectal cancer via regulation of Akt signaling. Pathol Oncol Res. 2017;23(3):651–656.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhai Y, Wang W, et al. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT. Gene. 2018;678:377–383.
   PubMed Web of Science ®Google Scholar
• Liu Z-Q, He W-F, Wu Y-J, et al. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis. BMC Gastroenterol. 2020;20(1):156.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song X, Wang X, et al. Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in human gastric cancer. J Med Biochem. 2016;35(2):137–143.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Y, Shang J, et al. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis. Eur Rev Med Pharmacol Sci. 2019;23(10):4185–4191.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Rezanejad H, Asadi MH, et al. LncRNA LOC100507144 acts as a novel regulator of CD44/Nanog/Sox2/miR-302/miR-21 axis in colorectal cancer. BioFactors. 2022;48(1):164–180.
   PubMed Web of Science ®Google Scholar
• Tang XH, Guo T, Gao XY, et al. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer. 2021;20(1):99.
   PubMed Web of Science ®Google Scholar
• Ge L, Zhang N, Li D, et al. Circulating exosomal small RNAs are promising non-invasive diagnostic biomarkers for gastric cancer. J Cell Mol Med. 2020;24(24):14502–14513.
   PubMed Web of Science ®Google Scholar
• Qin Y, Huo Z, Song X, et al. Mir-106a regulates cell proliferation and apoptosis of colon cancer cells through targeting the PTEN/PI3K/AKT signaling pathway. Oncol Lett. 2018;15(3):3197–3201.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu R, Yang F, et al. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1. Mol Cancer. 2017;16(1):53.
   PubMedGoogle Scholar
• Lu H, Hao L, Yang H, et al. miRNA-34a suppresses colon carcinoma proliferation and induces cell apoptosis by targeting SYT1. Int J Clin Exp Pathol. 2019;12(8):2887–2897.
   PubMed Web of Science ®Google Scholar
• Jung G, Hernández-Illán E, Moreira L, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–130.
   PubMed Web of Science ®Google Scholar
• Luo ZF, Zhao D, Li XQ, et al. Clinical significance of HOTAIR expression in colon cancer. World J Gastroenterol. 2016;22(22):5254–5259.
   PubMed Web of Science ®Google Scholar
• Zhao R, Zhang Y, Zhang X, et al. Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer. Mol Cancer. 2018;17(1):68.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang M, Zhang H, et al. Exosomal long noncoding RNA lnc-GNAQ-6: 1 may serve as a diagnostic marker for gastric cancer. Clin Chim Acta. 2020;501:252–257.
   PubMed Web of Science ®Google Scholar
• Ebrahimi N, Faghihkhorasani F, Fakhr SS, et al. Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer. Cell Mol Life Sci. 2022;79(11):572.
   PubMed Web of Science ®Google Scholar
• Zhao W, Song M, Zhang J, et al. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma. Int J Clin Exp Pathol. 2015;8(11):14131–14140.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo CC, Guan DH, et al. Prognostic value of microRNA-224 in various cancers: a meta-analysis. Arch Med Res. 2017;48(5):472–482.
   PubMed Web of Science ®Google Scholar
• Poli V, Seclì L, Avalle L. The microRNA-143/145 cluster in tumors: a matter of where and when. Cancers (Basel). 2020 Mar 17;12(3):708. doi: 10.3390/cancers12030708
   PubMed Web of Science ®Google Scholar
• Li Q, Li B, Li Q, et al. Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis. 2018;9(9):854.
   PubMedGoogle Scholar
• Wang X, Zhang H, Bai M, et al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer. Mol Ther. 2018;26(3):774–783.
   PubMed Web of Science ®Google Scholar
• Ji R, Zhang X, Gu H, et al. miR-374a-5p: a New target for diagnosis and drug resistance therapy in gastric cancer. Mol Ther Nucleic Acids. 2019;18:320–331.
   PubMedGoogle Scholar
• Lin L-Y, Yang L, Zeng Q, et al. Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer. Mol Cancer. 2018;17(1):84.
   PubMed Web of Science ®Google Scholar
• Kumata Y, Iinuma H, Suzuki Y, et al. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage. Oncol Rep. 2018;40(1):319–330.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Wang ZY, Chen R, et al. Macrophage-secreted Exosomes Delivering miRNA-21 Inhibitor can Regulate BGC-823 Cell Proliferation. Asian Pac J Cancer Prev. 2015;16(10):4203–4209.
   PubMedGoogle Scholar
• Xu Y, Zhang G, Zou C, et al. LncRNA MT1JP suppresses gastric cancer cell proliferation and migration through MT1JP/MiR-214-3p/RUNX3 axis. Cell Physiol Biochem. 2018;46(6):2445–2459.
   PubMedGoogle Scholar
• Yang TS, Yang XH, Wang XD, et al. MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int. 2013;13(1):68.
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Hirata I, et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010;17(6):398–408.
   PubMed Web of Science ®Google Scholar
• Beg MS, Brenner AJ, Sachdev J, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs. 2017;35(2):180–188.
   PubMed Web of Science ®Google Scholar
• Nedaeinia R, Avan A, Ahmadian M, et al. Current status and perspectives regarding LNA-Anti-miR oligonucleotides and microRNA miR-21 inhibitors as a potential therapeutic option in treatment of colorectal cancer. J Cell Biochem. 2017;118(12):4129–4140.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang L, Yang Y, et al. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochem Biophys Res Commun. 2017;493(3):1322–1328.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang L-N, Li W, et al. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci. 2018;109(5):1393–1403.
   PubMed Web of Science ®Google Scholar
• Yue D, Li H, Che J, et al. Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res. 2014;33(1):1–7.
   PubMedGoogle Scholar
• Zhang Y, Liu X, Zhang J, et al. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. Aging. 2020;12(7):5640–5650.
   PubMedGoogle Scholar